These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9080914)

  • 21. Aminorex to fen/phen: an epidemic foretold.
    Fishman AP
    Circulation; 1999 Jan 5-12; 99(1):156-61. PubMed ID: 9884392
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity].
    Benedetti A; Busonera G; Cattano G
    Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163
    [No Abstract]   [Full Text] [Related]  

  • 23. Lemons for obesity.
    Lauer MS
    Ann Intern Med; 2012 Jul; 157(2):139-40. PubMed ID: 22801677
    [No Abstract]   [Full Text] [Related]  

  • 24. New agent for obesity management.
    Schmitt SA
    J Fam Pract; 1996 Sep; 43(3):225. PubMed ID: 8797742
    [No Abstract]   [Full Text] [Related]  

  • 25. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for obesity -- do the benefits outweigh the risks?
    Manson JE; Faich GA
    N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523
    [No Abstract]   [Full Text] [Related]  

  • 28. In memory of dexfenfluramine: R.I.P.
    Carruba MO; Nisoli E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1193. PubMed ID: 9426390
    [No Abstract]   [Full Text] [Related]  

  • 29. Obesity.
    Arterburn D
    Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug to treat obesity: editorial writer responds.
    Faich GA
    CMAJ; 1997 Apr; 156(7):978. PubMed ID: 9099162
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 33. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 34. Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3.
    Rothman RB; Hendricks EJ
    Int J Cardiol; 2010 Oct; 144(2):241-2; author reply 242-3. PubMed ID: 19189876
    [No Abstract]   [Full Text] [Related]  

  • 35. Fenfluramine in the treatment of obesity.
    Spence AW; Medvei VC
    Br J Clin Pract; 1966 Dec; 20(12):643-4. PubMed ID: 5974503
    [No Abstract]   [Full Text] [Related]  

  • 36. Diet pill psychosis.
    Hoffman BF
    Can Med Assoc J; 1977 Feb; 116(4):351-5. PubMed ID: 844014
    [No Abstract]   [Full Text] [Related]  

  • 37. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 38. New agent for obesity management.
    Barkin RL
    J Fam Pract; 1996 Sep; 43(3):224. PubMed ID: 8797740
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of obesity. Appetite suppressant drugs and intestinal by-pass surgery.
    Bleehen SS; Edwards IR; Clark RG
    Br J Dermatol; 1976 Aug; 95(2):219-222. PubMed ID: 782507
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological approaches to intervention.
    Guy-Grand B
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.